I’ve had enough Anna and Rose for a lifetime. Twelve years (for me) of them eating away at my faith that something good would eventually happen with GNBT, and in the end they vanished leaving millions in debt behind. That debt may have been attractive to Joe but it was of no value to me.
New investors are always adding to the excitement that we’re just about to turn the corner. Hark! An important filing will occur tomorrow! And uplist in...6 weeks! After Anna and Rose, and the snail’s pace of vaccine development, it’s hard to work up any enthusiasm.
(3)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links